Viewing Study NCT06843967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-05-21 @ 7:26 PM
Study NCT ID: NCT06843967
Status: RECRUITING
Last Update Posted: 2025-11-12
First Post: 2025-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Well Differentiated Liposarcoma View
None Dedifferentiated Liposarcoma View
None Liposarcoma View
None Myxoid Liposarcoma View
None Round Cell Liposarcoma View
None Myxoid Pleomorphic Liposarcoma View
None Pleomorphic Liposarcoma View
None Unresectable Liposarcoma View
None Unresectable Dedifferentiated Liposarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Well Differentiated Liposarcoma View
None Dedifferentiated Liposarcoma View
None Liposarcoma View
None Myxoid Liposarcoma View
None Round Cell Liposarcoma View
None Myxoid Pleomorphic Liposarcoma View
None Pleomorphic Liposarcoma View
None Unresectable Liposarcoma View
None Unresectable Dedifferentiated Liposarcoma View
None Unresectable Well Differentiated Liposarcoma View
None 24-344 View
None Memorial Sloan Kettering Cancer Center View